Glenn Sblendorio
Chief Executive Officer at IVERIC BIO, INC.
Net worth: 984 761 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Bradley Campbell | M | 48 | 18 years | |
Srini Akkaraju Akkaraju | M | 56 | 12 years | |
Mark Reisenauer | M | 58 | 1 years | |
Jerome B. Durso | M | 56 | 7 years | |
Rocco Venezia | M | 48 | 8 years | |
Mike Raab Raab | M | 59 | 20 years | |
BT Slingsby | M | 47 | 5 years | |
Jared M. Freedberg | M | 55 | 3 years | |
Eiry Roberts | M | 60 | 3 years | |
Adam Levy | M | 46 | 2 years | |
Derek DiRocco | M | 43 | 2 years | |
Dhaval Desai | M | - | 4 years | |
Ellen Rosenberg | F | 61 | 8 years | |
Jon Congleton | M | 60 | 4 years | |
Jill Weimer | M | - | 5 years | |
Evelyn Harrison | F | - | 17 years | |
Alexander G. Asam | M | 58 | 3 years | |
Margaret McGlynn | F | 64 | 15 years | |
Kathy Galante | F | - | 11 years | |
Daphne Karydas | F | 49 | 1 years | |
Lynn Bleil | F | 60 | 6 years | |
Burke W. Whitman | M | 68 | 5 years | |
Olivier Litzka | M | 56 | 2 years | |
Craig Wheeler | M | 63 | 8 years | |
Michael Kelly | M | 67 | 4 years | |
Stefano Pasi | M | - | 1 years | |
Francesco Balestrieri | M | 55 | 1 years | |
Mitchell Goldman | M | - | 4 years | |
Xiao Ping Dai | M | - | - | |
Julie Clark | M | - | - | |
Christopher Simms | M | 49 | 3 years | |
Jessica Ibbitson | F | - | 3 years | |
Andrew Faughnan | M | - | - | |
David Rodman | M | 68 | 3 years | |
David Clark | M | 49 | 6 years | |
Samantha Prout | F | 46 | 6 years | |
Patrik Florencio | M | - | 9 years | |
Andrew Saik | M | 54 | 3 years | |
M. Berrey | M | 57 | 3 years | |
Linda M. Richardson | F | 60 | 6 years | |
Sébastien Martel | M | - | 3 years | |
Diana Moore | F | - | 9 years | |
Simon Harford | M | 64 | 1 years | |
Jeffrey Castelli | M | - | 19 years | |
Haichen Yang | F | - | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Guyer | M | 64 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 20 years |
Daphne Quimi | F | 58 | 18 years | |
John Crowley | M | 57 | 22 years | |
Mark Pruzanski | M | 56 | 21 years | |
Bruce Peacock | M | 72 | 4 years | |
Barbara Duncan | F | 59 | 7 years | |
Jonathan Silverstein | M | 57 | 7 years | |
Paolo Fundarò | M | 50 | 17 years | |
David M. Stack | M | 72 | 3 years | |
Donald Hayden | M | 68 | 12 years | |
John M. McAdam | M | 49 | 4 years | |
Samir Chandrakant Patel | M | 62 | 10 years | |
Lorenzo M. Tallarigo | M | 74 | 6 years | |
David Carroll | M | 58 | 8 years | |
Adrienne Graves | M | 69 | 5 years | |
Pravin Dugel | M | 60 | 3 years | |
S. Schaeffer | F | 55 | 7 years | |
Ryan Sullivan | M | 48 | 2 years | |
Todd Anderman | M | - | - | |
Bryan Yoon | M | 47 | 4 years | |
Hiroaki Shigeta | M | 81 | - | |
Mark Vignola | M | 46 | 4 years | |
Sandipkumar S. Kapadia | M | 53 | 5 years | |
Keith Gottesdiener | M | 70 | 7 years | |
Nancy Miller-Rich | F | 65 | 5 years | |
Neera D. Ravindran | M | - | - | |
Sanj Patel | M | 54 | 1 years | |
Gregory C. Williams | M | 65 | 7 years | |
Hung Do | M | 55 | - | |
Melvin Spigelman | M | 75 | 13 years | |
Matt Patterson | M | 52 | 6 years | |
Marty Glick | M | 74 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | - |
Fred M. Ryan | M | 72 | 5 years | |
Dennis P. Reilly | M | 65 | 3 years | |
Elizabeth Hamilton Seabury Wyatt | M | 76 | - | |
Robert G. Savage | M | 70 | 13 years | |
Nicholas G. Galakatos | M | 66 | 7 years | |
Michael Ross | M | 75 | 6 years | |
Gino Santini | M | 66 | 8 years | |
Paul Chaney | M | 66 |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | 10 years |
Klaus Veitinger | M | 62 | 4 years | |
John Kelley | M | 70 | 5 years | |
Nicholas Aynilian | M | 60 |
Fairleigh Dickinson University
| 6 years |
Bill O'Connor | M | 64 | 12 years | |
Thomas Dyrberg | M | 69 | 12 years | |
Robert Hugin | M | 69 | 15 years | |
William W. Crouse | M | 80 | 15 years | |
Daniel Bradbury | M | 62 | 7 years | |
Daniel Welch | M | 66 | 6 years | |
Nicole S. Williams | F | 79 | 7 years | |
Gregory Mark Weinhoff | M | 53 | 7 years | |
Axel Bolte | M | 52 | 16 years | |
James Topper | M | 62 | 11 years | |
Luca Benatti | M | 63 | 9 years | |
Bryan Ball | M | 54 | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Glenn Sblendorio
- Personal Network